Literature DB >> 15177682

Comparative genomics: the evolutionary history of the Bcl-2 family.

Cecilia Lanave1, Monica Santamaria, Cecilia Saccone.   

Abstract

The Bcl-2 family is a huge family composed of various members, occurring in all animals, which are key regulators of apoptosis, the cell death program critical for cell survival and development, tissue homeostasis, and protection against pathogens. The members of the Bcl-2 family can be divided into pro-apoptotic and anti-apoptotic proteins. A delicate balance between these members exists in each cell and the regulations of these two groups of proteins determines whether the cell survives or undergoes apoptosis. Bcl-2 family proteins are characterized by distinct domains. All members possess at least one of the four motifs known as Bcl-2 homology domains (BH1 to BH4). Most pro-survival members which can inhibit apoptosis facing a wide variety of cytotoxic insults, contain at least BH1 and BH2 domains; those most similar to Bcl-2 have all four BH domains. All the pro-apoptosis family members possess BH3 domain which is the central domain. For the first time, a global phylogenetic analysis of all Bcl-2 family members is presented here. We have analyzed the genes known so far that have a different composition of the functional domains BH1, BH2, BH3 and BH4. The analyses were performed both on complete sequences (124 sites analyzed) and on single domains. We present the results obtained using both approaches. We have also analyzed the amino acid profile and the degree of conservation of the BH3 domains of pro- and anti-apoptotic proteins. The results of our phylogenetic analyses show that a clear-cut clustering into pro- and anti-apoptotic products, reproducible with different evolutionary methods, could also be obtained by analyzing restricted areas such as the BH1 and BH2 domains. It is noteworthy that even when the analysis is performed only on the BH3 domain, we have two clear-cut clusters. The evolutionary analysis of gene family members is a valuable tool to predict their functions and guide experimental assays to validate predictions. Once the functions of all the components are known, it will be possible to study the process in a holistic way.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177682     DOI: 10.1016/j.gene.2004.02.017

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  30 in total

1.  Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like molecule.

Authors:  Lixia Zhao; Feng He; Haiyang Liu; Yushan Zhu; Weili Tian; Ping Gao; Hongping He; Wen Yue; Xiaobo Lei; Biyun Ni; Xiaohui Wang; Haijing Jin; Xiaojiang Hao; Jialing Lin; Quan Chen
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

2.  Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells.

Authors:  Feng Dong; Mustak Pirbhai; Yangming Xiao; Youmin Zhong; Yimou Wu; Guangming Zhong
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1.

Authors:  Levi J Beverly; William W Lockwood; Parag P Shah; Hediye Erdjument-Bromage; Harold Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-10       Impact factor: 11.205

4.  BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins.

Authors:  Levi J Beverly; Lauren A Howell; Maria Hernandez-Corbacho; Lavona Casson; Jerry E Chipuk; Leah J Siskind
Journal:  Biochem J       Date:  2013-05-15       Impact factor: 3.857

5.  MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family.

Authors:  L J Beverly; H E Varmus
Journal:  Oncogene       Date:  2009-01-12       Impact factor: 9.867

Review 6.  BH3-only proteins in apoptosis and beyond: an overview.

Authors:  E Lomonosova; G Chinnadurai
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

7.  Ultra-High-Throughput Screening of Natural Product Extracts to Identify Proapoptotic Inhibitors of Bcl-2 Family Proteins.

Authors:  Christian A Hassig; Fu-Yue Zeng; Paul Kung; Mehrak Kiankarimi; Sylvia Kim; Paul W Diaz; Dayong Zhai; Kate Welsh; Shana Morshedian; Ying Su; Barry O'Keefe; David J Newman; Yudi Rusman; Harneet Kaur; Christine E Salomon; Susan G Brown; Beeraiah Baire; Andrew R Michel; Thomas R Hoye; Subhashree Francis; Gunda I Georg; Michael A Walters; Daniela B Divlianska; Gregory P Roth; Amy E Wright; John C Reed
Journal:  J Biomol Screen       Date:  2014-05-27

8.  Regulation of apoptosis by C. elegans CED-9 in the absence of the C-terminal transmembrane domain.

Authors:  F J Tan; A Z Fire; R B Hill
Journal:  Cell Death Differ       Date:  2007-08-17       Impact factor: 15.828

9.  Change in expression of apoptosis genes after hyperthermia, chemotherapy and radiotherapy in human colon cancer transplanted into nude mice.

Authors:  Han Liang; Hong-Jie Zhan; Bao-Gui Wang; Yuan Pan; Xi-Shan Hao
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

10.  Mapping the interaction of pro-apoptotic tBID with pro-survival BCL-XL.

Authors:  Yong Yao; Andrey A Bobkov; Leigh A Plesniak; Francesca M Marassi
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.